Answers are grounded in this paper and cite their sources.
Preclinical studies on bacterial-type strains suggest that modulation of sRNAs could enhance bacterial susceptibility to antibiotics. Further studies on clinical isolates and in vivo models are needed to elucidate the therapeutic value of sRNA modulation on treatment of multidrug-resistant bacterial infection.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: